ID   ATF4_HUMAN              Reviewed;         351 AA.
AC   P18848; Q96AQ3; Q9UH31;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   18-JUN-2025, entry version 245.
DE   RecName: Full=Cyclic AMP-dependent transcription factor ATF-4 {ECO:0000305};
DE            Short=cAMP-dependent transcription factor ATF-4 {ECO:0000305};
DE   AltName: Full=Activating transcription factor 4 {ECO:0000303|PubMed:2516827};
DE   AltName: Full=Cyclic AMP-responsive element-binding protein 2 {ECO:0000303|PubMed:1534408};
DE            Short=CREB-2 {ECO:0000303|PubMed:1534408};
DE            Short=cAMP-responsive element-binding protein 2 {ECO:0000303|PubMed:1534408};
DE   AltName: Full=Tax-responsive enhancer element-binding protein 67 {ECO:0000303|PubMed:1847461};
DE            Short=TaxREB67 {ECO:0000303|PubMed:1847461};
GN   Name=ATF4 {ECO:0000303|PubMed:2516827, ECO:0000312|HGNC:HGNC:786};
GN   Synonyms=CREB2 {ECO:0000303|PubMed:1534408}, TXREB
GN   {ECO:0000303|PubMed:1847461};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND VARIANT PRO-22.
RC   TISSUE=Fibroblast;
RX   PubMed=1847461; DOI=10.1128/jvi.65.3.1420-1426.1991;
RA   Tsujimoto A., Nyunoya H., Morita T., Sato T., Shimotohno K.;
RT   "Isolation of cDNAs for DNA-binding proteins which specifically bind to a
RT   tax-responsive enhancer element in the long terminal repeat of human T-cell
RT   leukemia virus type I.";
RL   J. Virol. 65:1420-1426(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PRO-22.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=1534408; DOI=10.1073/pnas.89.11.4820;
RA   Karpinski B.A., Morle G.D., Huggenvik J., Uhler M.D., Leiden J.M.;
RT   "Molecular cloning of human CREB-2: an ATF/CREB transcription factor that
RT   can negatively regulate transcription from the cAMP response element.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:4820-4824(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-22.
RC   TISSUE=Colon, Lung, Placenta, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 274-341.
RX   PubMed=2516827; DOI=10.1101/gad.3.12b.2083;
RA   Hai T., Liu F., Coukos W.J., Green M.R.;
RT   "Transcription factor ATF cDNA clones: an extensive family of leucine
RT   zipper proteins able to selectively form DNA-binding heterodimers.";
RL   Genes Dev. 3:2083-2090(1989).
RN   [8]
RP   ERRATUM OF PUBMED:2516827.
RA   Hai T., Liu F., Coukos W.J., Green M.R.;
RL   Genes Dev. 4:682-682(1990).
RN   [9]
RP   UBIQUITINATION.
RX   PubMed=11238952; DOI=10.1128/mcb.21.6.2192-2202.2001;
RA   Lassot I., Segeral E., Berlioz-Torrent C., Durand H., Groussin L., Hai T.,
RA   Benarous R., Margottin-Goguet F.;
RT   "ATF4 degradation relies on a phosphorylation-dependent interaction with
RT   the SCF(betaTrCP) ubiquitin ligase.";
RL   Mol. Cell. Biol. 21:2192-2202(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=11960987; DOI=10.1074/jbc.m201959200;
RA   Siu F., Bain P.J., LeBlanc-Chaffin R., Chen H., Kilberg M.S.;
RT   "ATF4 is a mediator of the nutrient-sensing response pathway that activates
RT   the human asparagine synthetase gene.";
RL   J. Biol. Chem. 277:24120-24127(2002).
RN   [11]
RP   FUNCTION, PHOSPHORYLATION AT SER-245, AND MUTAGENESIS OF SER-245.
RX   PubMed=15109498; DOI=10.1016/s0092-8674(04)00344-7;
RA   Yang X., Matsuda K., Bialek P., Jacquot S., Masuoka H.C., Schinke T.,
RA   Li L., Brancorsini S., Sassone-Corsi P., Townes T.M., Hanauer A.,
RA   Karsenty G.;
RT   "ATF4 is a substrate of RSK2 and an essential regulator of osteoblast
RT   biology; implication for Coffin-Lowry Syndrome.";
RL   Cell 117:387-398(2004).
RN   [12]
RP   FUNCTION.
RX   PubMed=15775988; DOI=10.1038/sj.emboj.7600596;
RA   Ohoka N., Yoshii S., Hattori T., Onozaki K., Hayashi H.;
RT   "TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway
RT   and is involved in cell death.";
RL   EMBO J. 24:1243-1255(2005).
RN   [13]
RP   ACETYLATION AT LYS-311, UBIQUITINATION, SUBCELLULAR LOCATION, INTERACTION
RP   WITH EP300, AND MUTAGENESIS OF SER-219 AND LYS-311.
RX   PubMed=16219772; DOI=10.1074/jbc.m505294200;
RA   Lassot I., Estrabaud E., Emiliani S., Benkirane M., Benarous R.,
RA   Margottin-Goguet F.;
RT   "p300 modulates ATF4 stability and transcriptional activity independently
RT   of its acetyltransferase domain.";
RL   J. Biol. Chem. 280:41537-41545(2005).
RN   [14]
RP   INTERACTION WITH TXLNG.
RX   PubMed=15911876; DOI=10.1083/jcb.200412139;
RA   Yu V.W., Ambartsoumian G., Verlinden L., Moir J.M., Prud'homme J.,
RA   Gauthier C., Roughley P.J., St-Arnaud R.;
RT   "FIAT represses ATF4-mediated transcription to regulate bone mass in
RT   transgenic mice.";
RL   J. Cell Biol. 169:591-601(2005).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CEP290.
RX   PubMed=16682973; DOI=10.1038/ng1786;
RA   Sayer J.A., Otto E.A., O'toole J.F., Nurnberg G., Kennedy M.A., Becker C.,
RA   Hennies H.C., Helou J., Attanasio M., Fausett B.V., Utsch B., Khanna H.,
RA   Liu Y., Drummond I., Kawakami I., Kusakabe T., Tsuda M., Ma L., Lee H.,
RA   Larson R.G., Allen S.J., Wilkinson C.J., Nigg E.A., Shou C., Lillo C.,
RA   Williams D.S., Hoppe B., Kemper M.J., Neuhaus T., Parisi M.A., Glass I.A.,
RA   Petry M., Kispert A., Gloy J., Ganner A., Walz G., Zhu X., Goldman D.,
RA   Nurnberg P., Swaroop A., Leroux M.R., Hildebrandt F.;
RT   "The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and
RT   activates transcription factor ATF4.";
RL   Nat. Genet. 38:674-681(2006).
RN   [16]
RP   HYDROXYLATION, AND MUTAGENESIS OF PRO-156; PRO-162; PRO-164; PRO-167 AND
RP   PRO-174.
RX   PubMed=17684156; DOI=10.1182/blood-2007-06-094441;
RA   Koeditz J., Nesper J., Wottawa M., Stiehl D.P., Camenisch G., Franke C.,
RA   Myllyharju J., Wenger R.H., Katschinski D.M.;
RT   "Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor.";
RL   Blood 110:3610-3617(2007).
RN   [17]
RP   FUNCTION, AND INTERACTION WITH DDIT3.
RX   PubMed=18940792; DOI=10.1074/jbc.m806874200;
RA   Su N., Kilberg M.S.;
RT   "C/EBP homology protein (CHOP) interacts with activating transcription
RT   factor 4 (ATF4) and negatively regulates the stress-dependent induction of
RT   the asparagine synthetase gene.";
RL   J. Biol. Chem. 283:35106-35117(2008).
RN   [18]
RP   SUBCELLULAR LOCATION, INTERACTION WITH NEK6, AND PHOSPHORYLATION.
RX   PubMed=20873783; DOI=10.1021/pr100562w;
RA   Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C., Santana Bernachi J.,
RA   Paes Leme A.F., Kobarg J.;
RT   "Characterization of hNek6 interactome reveals an important role for its
RT   short N-terminal domain and colocalization with proteins at the
RT   centrosome.";
RL   J. Proteome Res. 9:6298-6316(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   INTERACTION WITH DAPK2 AND ZIPK/DAPK3.
RX   PubMed=21408167; DOI=10.1371/journal.pone.0017344;
RA   Shoval Y., Berissi H., Kimchi A., Pietrokovski S.;
RT   "New modularity of DAP-kinases: alternative splicing of the DRP-1 gene
RT   produces a ZIPk-like isoform.";
RL   PLoS ONE 6:E17344-E17344(2011).
RN   [21]
RP   INTERACTION WITH ABRAXAS2, AND SUBCELLULAR LOCATION.
RX   PubMed=22974638; DOI=10.1016/j.bbamcr.2012.08.020;
RA   Ambivero C.T., Cilenti L., Zervos A.S.;
RT   "ATF4 interacts with Abro1/KIAA0157 scaffold protein and participates in a
RT   cytoprotective pathway.";
RL   Biochim. Biophys. Acta 1823:2149-2156(2012).
RN   [22]
RP   PHOSPHORYLATION AT SER-215, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   THR-213 AND SER-215.
RX   PubMed=23123191; DOI=10.1016/j.bbamcr.2012.10.025;
RA   Ampofo E., Sokolowsky T., Goetz C., Montenarh M.;
RT   "Functional interaction of protein kinase CK2 and activating transcription
RT   factor 4 (ATF4), a key player in the cellular stress response.";
RL   Biochim. Biophys. Acta 1833:439-451(2013).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-267, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [24]
RP   FUNCTION.
RX   PubMed=26086088; DOI=10.1371/journal.pone.0130635;
RA   D'Osualdo A., Anania V.G., Yu K., Lill J.R., Kaufman R.J., Matsuzawa S.,
RA   Reed J.C.;
RT   "Transcription factor ATF4 induces NLRP1 inflammasome expression during
RT   endoplasmic reticulum stress.";
RL   PLoS ONE 10:E0130635-E0130635(2015).
RN   [25]
RP   REVIEW.
RX   PubMed=27629041; DOI=10.15252/embr.201642195;
RA   Pakos-Zebrucka K., Koryga I., Mnich K., Ljujic M., Samali A., Gorman A.M.;
RT   "The integrated stress response.";
RL   EMBO Rep. 17:1374-1395(2016).
RN   [26]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-53; LYS-259; LYS-267 AND LYS-272,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [27]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=31023583; DOI=10.1016/j.molcel.2019.03.031;
RA   Balsa E., Soustek M.S., Thomas A., Cogliati S., Garcia-Poyatos C.,
RA   Martin-Garcia E., Jedrychowski M., Gygi S.P., Enriquez J.A., Puigserver P.;
RT   "ER and nutrient stress promote assembly of respiratory chain
RT   supercomplexes through the PERK-eIF2alpha axis.";
RL   Mol. Cell 74:877-890(2019).
RN   [28]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=31444471; DOI=10.1038/s41380-019-0485-2;
RA   Wang X., Ye F., Wen Z., Guo Z., Yu C., Huang W.K., Rojas Ringeling F.,
RA   Su Y., Zheng W., Zhou G., Christian K.M., Song H., Zhang M., Ming G.L.;
RT   "Structural interaction between DISC1 and ATF4 underlying transcriptional
RT   and synaptic dysregulation in an iPSC model of mental disorders.";
RL   Mol. Psychiatry 26:1346-1360(2021).
RN   [29]
RP   FUNCTION.
RX   PubMed=32132706; DOI=10.1038/s41586-020-2076-4;
RA   Fessler E., Eckl E.M., Schmitt S., Mancilla I.A., Meyer-Bender M.F.,
RA   Hanf M., Philippou-Massier J., Krebs S., Zischka H., Jae L.T.;
RT   "A pathway coordinated by DELE1 relays mitochondrial stress to the
RT   cytosol.";
RL   Nature 579:433-437(2020).
RN   [30]
RP   FUNCTION.
RX   PubMed=32132707; DOI=10.1038/s41586-020-2078-2;
RA   Guo X., Aviles G., Liu Y., Tian R., Unger B.A., Lin Y.T., Wiita A.P.,
RA   Xu K., Correia M.A., Kampmann M.;
RT   "Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI
RT   pathway.";
RL   Nature 579:427-432(2020).
RN   [31]
RP   FUNCTION, AND INDUCTION BY ER STRESS.
RX   PubMed=33384352; DOI=10.1126/science.abb6896;
RA   You K., Wang L., Chou C.H., Liu K., Nakata T., Jaiswal A., Yao J.,
RA   Lefkovith A., Omar A., Perrigoue J.G., Towne J.E., Regev A., Graham D.B.,
RA   Xavier R.J.;
RT   "QRICH1 dictates the outcome of ER stress through transcriptional control
RT   of proteostasis.";
RL   Science 371:0-0(2021).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 279-341 IN COMPLEX WITH MOUSE
RP   CEBPB, INTERACTION WITH CEBPB, AND DNA-BINDING.
RX   PubMed=11018027; DOI=10.1074/jbc.m005594200;
RA   Podust L.M., Krezel A.M., Kim Y.;
RT   "Crystal structure of the CCAAT box/enhancer-binding protein beta
RT   activating transcription factor-4 basic leucine zipper heterodimer in the
RT   absence of DNA.";
RL   J. Biol. Chem. 276:505-513(2001).
CC   -!- FUNCTION: Transcription factor that binds the cAMP response element
CC       (CRE) (consensus: 5'-GTGACGT[AC][AG]-3') and displays two biological
CC       functions, as regulator of metabolic and redox processes under normal
CC       cellular conditions, and as master transcription factor during
CC       integrated stress response (ISR) (PubMed:16682973, PubMed:17684156,
CC       PubMed:31023583, PubMed:31444471, PubMed:32132707). Binds to asymmetric
CC       CRE's as a heterodimer and to palindromic CRE's as a homodimer (By
CC       similarity). Core effector of the ISR, which is required for adaptation
CC       to various stress such as endoplasmic reticulum (ER) stress, amino acid
CC       starvation, mitochondrial stress or oxidative stress (PubMed:31023583,
CC       PubMed:32132707). During ISR, ATF4 translation is induced via an
CC       alternative ribosome translation re-initiation mechanism in response to
CC       EIF2S1/eIF-2-alpha phosphorylation, and stress-induced ATF4 acts as a
CC       master transcription factor of stress-responsive genes in order to
CC       promote cell recovery (PubMed:31023583, PubMed:32132706,
CC       PubMed:32132707). Promotes the transcription of genes linked to amino
CC       acid sufficiency and resistance to oxidative stress to protect cells
CC       against metabolic consequences of ER oxidation (By similarity).
CC       Activates the transcription of NLRP1, possibly in concert with other
CC       factors in response to ER stress (PubMed:26086088). Activates the
CC       transcription of asparagine synthetase (ASNS) in response to amino acid
CC       deprivation or ER stress (PubMed:11960987). However, when associated
CC       with DDIT3/CHOP, the transcriptional activation of the ASNS gene is
CC       inhibited in response to amino acid deprivation (PubMed:18940792).
CC       Together with DDIT3/CHOP, mediates programmed cell death by promoting
CC       the expression of genes involved in cellular amino acid metabolic
CC       processes, mRNA translation and the terminal unfolded protein response
CC       (terminal UPR), a cellular response that elicits programmed cell death
CC       when ER stress is prolonged and unresolved (By similarity). Activates
CC       the expression of COX7A2L/SCAF1 downstream of the EIF2AK3/PERK-mediated
CC       unfolded protein response, thereby promoting formation of respiratory
CC       chain supercomplexes and increasing mitochondrial oxidative
CC       phosphorylation (PubMed:31023583). Together with DDIT3/CHOP, activates
CC       the transcription of the IRS-regulator TRIB3 and promotes ER stress-
CC       induced neuronal cell death by regulating the expression of BBC3/PUMA
CC       in response to ER stress (PubMed:15775988). May cooperate with the UPR
CC       transcriptional regulator QRICH1 to regulate ER protein homeostasis
CC       which is critical for cell viability in response to ER stress
CC       (PubMed:33384352). In the absence of stress, ATF4 translation is at low
CC       levels and it is required for normal metabolic processes such as
CC       embryonic lens formation, fetal liver hematopoiesis, bone development
CC       and synaptic plasticity (By similarity). Acts as a regulator of
CC       osteoblast differentiation in response to phosphorylation by
CC       RPS6KA3/RSK2: phosphorylation in osteoblasts enhances transactivation
CC       activity and promotes expression of osteoblast-specific genes and post-
CC       transcriptionally regulates the synthesis of Type I collagen, the main
CC       constituent of the bone matrix (PubMed:15109498). Cooperates with FOXO1
CC       in osteoblasts to regulate glucose homeostasis through suppression of
CC       beta-cell production and decrease in insulin production (By
CC       similarity). Activates transcription of SIRT4 (By similarity).
CC       Regulates the circadian expression of the core clock component PER2 and
CC       the serotonin transporter SLC6A4 (By similarity). Binds in a circadian
CC       time-dependent manner to the cAMP response elements (CRE) in the SLC6A4
CC       and PER2 promoters and periodically activates the transcription of
CC       these genes (By similarity). Mainly acts as a transcriptional activator
CC       in cellular stress adaptation, but it can also act as a transcriptional
CC       repressor: acts as a regulator of synaptic plasticity by repressing
CC       transcription, thereby inhibiting induction and maintenance of long-
CC       term memory (By similarity). Regulates synaptic functions via
CC       interaction with DISC1 in neurons, which inhibits ATF4 transcription
CC       factor activity by disrupting ATF4 dimerization and DNA-binding
CC       (PubMed:31444471). {ECO:0000250|UniProtKB:Q06507,
CC       ECO:0000269|PubMed:11960987, ECO:0000269|PubMed:15109498,
CC       ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:16682973,
CC       ECO:0000269|PubMed:17684156, ECO:0000269|PubMed:18940792,
CC       ECO:0000269|PubMed:26086088, ECO:0000269|PubMed:31023583,
CC       ECO:0000269|PubMed:31444471, ECO:0000269|PubMed:32132706,
CC       ECO:0000269|PubMed:32132707, ECO:0000269|PubMed:33384352}.
CC   -!- FUNCTION: (Microbial infection) Binds to a Tax-responsive enhancer
CC       element in the long terminal repeat of HTLV-I.
CC       {ECO:0000269|PubMed:1847461}.
CC   -!- SUBUNIT: Binds DNA as a homodimer and as a heterodimer
CC       (PubMed:11018027). Heterodimer; heterodimerizes with CEBPB
CC       (PubMed:11018027). Heterodimer; heterodimerizes with DDIT3/CHOP
CC       (PubMed:18940792). Interacts with CEP290 (via an N-terminal region)
CC       (PubMed:16682973). Interacts with NEK6, DAPK2 (isoform 2) and
CC       ZIPK/DAPK3 (PubMed:20873783, PubMed:21408167). Interacts (via its
CC       leucine zipper domain) with GABBR1 and GABBR2 (via their C-termini) (By
CC       similarity). Forms a heterodimer with TXLNG in osteoblasts
CC       (PubMed:15911876). Interacts (via its DNA binding domain) with FOXO1
CC       (C-terminal half); the interaction occurs in osteoblasts and regulates
CC       glucose homeostasis through suppression of beta-cell proliferation and
CC       a decrease in insulin production (By similarity). Interacts with SATB2;
CC       the interaction results in enhanced DNA binding and transactivation by
CC       these transcription factors (By similarity). Interacts with ABRAXAS2
CC       (PubMed:22974638). Interacts with TRIB3, inhibiting the transactivation
CC       activity of ATF4 (By similarity). Interacts with DISC1; which inhibits
CC       ATF4 transcription factor activity by disrupting ATF4 dimerization and
CC       DNA-binding (By similarity). Interacts with EP300/p300; EP300/p300
CC       stabilizes ATF4 and increases its transcriptional activity
CC       independently of its catalytic activity by preventing its
CC       ubiquitination (PubMed:16219772). {ECO:0000250|UniProtKB:Q06507,
CC       ECO:0000250|UniProtKB:Q9ES19, ECO:0000269|PubMed:11018027,
CC       ECO:0000269|PubMed:15911876, ECO:0000269|PubMed:16219772,
CC       ECO:0000269|PubMed:16682973, ECO:0000269|PubMed:18940792,
CC       ECO:0000269|PubMed:20873783, ECO:0000269|PubMed:21408167,
CC       ECO:0000269|PubMed:22974638}.
CC   -!- INTERACTION:
CC       P18848; Q9BXS5: AP1M1; NbExp=3; IntAct=EBI-492498, EBI-541426;
CC       P18848; P15336: ATF2; NbExp=2; IntAct=EBI-492498, EBI-1170906;
CC       P18848; P18847: ATF3; NbExp=9; IntAct=EBI-492498, EBI-712767;
CC       P18848; P18848: ATF4; NbExp=2; IntAct=EBI-492498, EBI-492498;
CC       P18848; Q16520: BATF; NbExp=3; IntAct=EBI-492498, EBI-749503;
CC       P18848; Q9NR55: BATF3; NbExp=2; IntAct=EBI-492498, EBI-10312707;
CC       P18848; Q13515: BFSP2; NbExp=11; IntAct=EBI-492498, EBI-10229433;
CC       P18848; A0A0S2Z507: BTRC; NbExp=6; IntAct=EBI-492498, EBI-16429247;
CC       P18848; B7Z3H4: BTRC; NbExp=3; IntAct=EBI-492498, EBI-16429269;
CC       P18848; Q9Y297: BTRC; NbExp=21; IntAct=EBI-492498, EBI-307461;
CC       P18848; Q9Y297-2: BTRC; NbExp=5; IntAct=EBI-492498, EBI-8826333;
CC       P18848; P55212: CASP6; NbExp=3; IntAct=EBI-492498, EBI-718729;
CC       P18848; Q9BWC9: CCDC106; NbExp=14; IntAct=EBI-492498, EBI-711501;
CC       P18848; P49715: CEBPA; NbExp=4; IntAct=EBI-492498, EBI-1172054;
CC       P18848; P17676: CEBPB; NbExp=2; IntAct=EBI-492498, EBI-969696;
CC       P18848; P49716: CEBPD; NbExp=2; IntAct=EBI-492498, EBI-7962058;
CC       P18848; Q15744: CEBPE; NbExp=2; IntAct=EBI-492498, EBI-3907048;
CC       P18848; P53567: CEBPG; NbExp=16; IntAct=EBI-492498, EBI-740209;
CC       P18848; Q9Y592-2: CEP83; NbExp=3; IntAct=EBI-492498, EBI-11123098;
CC       P18848; Q9NS37: CREBZF; NbExp=7; IntAct=EBI-492498, EBI-632965;
CC       P18848; Q9UIK4-2: DAPK2; NbExp=2; IntAct=EBI-492498, EBI-9693115;
CC       P18848; P35638: DDIT3; NbExp=5; IntAct=EBI-492498, EBI-742651;
CC       P18848; Q9NRI5: DISC1; NbExp=4; IntAct=EBI-492498, EBI-529989;
CC       P18848; Q9NV70: EXOC1; NbExp=3; IntAct=EBI-492498, EBI-1045313;
CC       P18848; P01100: FOS; NbExp=4; IntAct=EBI-492498, EBI-852851;
CC       P18848; P15407: FOSL1; NbExp=2; IntAct=EBI-492498, EBI-744510;
CC       P18848; Q96CN9: GCC1; NbExp=6; IntAct=EBI-492498, EBI-746252;
CC       P18848; Q92805: GOLGA1; NbExp=11; IntAct=EBI-492498, EBI-6164177;
CC       P18848; Q0D2H9: GOLGA8DP; NbExp=3; IntAct=EBI-492498, EBI-10181276;
CC       P18848; Q08AF8: GOLGA8G; NbExp=7; IntAct=EBI-492498, EBI-10181260;
CC       P18848; Q13227: GPS2; NbExp=13; IntAct=EBI-492498, EBI-713355;
CC       P18848; Q99871: HAUS7; NbExp=3; IntAct=EBI-492498, EBI-395719;
CC       P18848; Q8WYK2: JDP2; NbExp=3; IntAct=EBI-492498, EBI-1248415;
CC       P18848; P05412: JUN; NbExp=4; IntAct=EBI-492498, EBI-852823;
CC       P18848; P17275: JUNB; NbExp=3; IntAct=EBI-492498, EBI-748062;
CC       P18848; P13473-2: LAMP2; NbExp=3; IntAct=EBI-492498, EBI-21591415;
CC       P18848; O95751: LDOC1; NbExp=10; IntAct=EBI-492498, EBI-740738;
CC       P18848; O75444: MAF; NbExp=3; IntAct=EBI-492498, EBI-2805091;
CC       P18848; Q96NT1: NAP1L5; NbExp=3; IntAct=EBI-492498, EBI-713627;
CC       P18848; O14777: NDC80; NbExp=8; IntAct=EBI-492498, EBI-715849;
CC       P18848; Q16236: NFE2L2; NbExp=8; IntAct=EBI-492498, EBI-2007911;
CC       P18848; P19387: POLR2C; NbExp=6; IntAct=EBI-492498, EBI-394729;
CC       P18848; O75400-2: PRPF40A; NbExp=3; IntAct=EBI-492498, EBI-5280197;
CC       P18848; Q86UD0: SAPCD2; NbExp=3; IntAct=EBI-492498, EBI-2561646;
CC       P18848; Q9Y371: SH3GLB1; NbExp=3; IntAct=EBI-492498, EBI-2623095;
CC       P18848; A2RTX5: TARS3; NbExp=3; IntAct=EBI-492498, EBI-1056629;
CC       P18848; Q3MII6: TBC1D25; NbExp=2; IntAct=EBI-492498, EBI-11899977;
CC       P18848; Q96RU7: TRIB3; NbExp=16; IntAct=EBI-492498, EBI-492476;
CC       P18848; P02766: TTR; NbExp=3; IntAct=EBI-492498, EBI-711909;
CC       P18848; O54784: Dapk3; Xeno; NbExp=2; IntAct=EBI-492498, EBI-77359;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16682973,
CC       ECO:0000269|PubMed:22974638, ECO:0000269|PubMed:23123191,
CC       ECO:0000269|PubMed:31444471}. Nucleus speckle
CC       {ECO:0000269|PubMed:16219772}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q9ES19}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q9ES19}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000269|PubMed:20873783}.
CC       Note=Colocalizes with GABBR1 in hippocampal neuron dendritic membranes
CC       (By similarity). Colocalizes with NEK6 at the centrosome
CC       (PubMed:20873783). Recruited to nuclear speckles following interaction
CC       with EP300/p300 (PubMed:16219772). {ECO:0000250|UniProtKB:Q9ES19,
CC       ECO:0000269|PubMed:16219772, ECO:0000269|PubMed:20873783}.
CC   -!- INDUCTION: Regulated at the translational level in response to various
CC       stress such as endoplasmic reticulum stress, amino acid starvation or
CC       oxidative stress (PubMed:27629041, PubMed:31023583, PubMed:33384352).
CC       In the absence of stress, ribosomes re-initiate translation at an
CC       inhibitory open reading frame (uORF) upstream of the ATF4 transcript,
CC       which precludes AFT4 translation. In response to stress and subsequent
CC       EIF2S1/eIF-2-alpha phosphorylation, ribosomes bypass the inhibitory
CC       uORF and re-initiate translation at the AFT4 coding sequence
CC       (PubMed:27629041). {ECO:0000269|PubMed:31023583,
CC       ECO:0000269|PubMed:33384352, ECO:0000303|PubMed:27629041}.
CC   -!- DOMAIN: The BetaTrCP degron motif promotes binding to BTRC when
CC       phosphorylated. {ECO:0000269|PubMed:11238952}.
CC   -!- PTM: Ubiquitinated by SCF(BTRC) in response to mTORC1 signal, followed
CC       by proteasomal degradation and leading to down-regulate expression of
CC       SIRT4 (PubMed:11238952). Interaction with EP300/p300 inhibits
CC       ubiquitination by SCF(BTRC) (PubMed:16219772).
CC       {ECO:0000269|PubMed:11238952, ECO:0000269|PubMed:16219772}.
CC   -!- PTM: Phosphorylation at Ser-245 by RPS6KA3/RSK2 in osteoblasts enhances
CC       transactivation activity and promotes osteoblast differentiation
CC       (PubMed:15109498). Phosphorylated on the betaTrCP degron motif at Ser-
CC       219, followed by phosphorylation at Thr-213, Ser-224, Ser-231, Ser-235
CC       and Ser-248, promoting interaction with BTRC and ubiquitination (By
CC       similarity). Phosphorylation is promoted by mTORC1 (By similarity).
CC       Phosphorylation at Ser-215 by CK2 decreases its stability
CC       (PubMed:23123191). Phosphorylated by NEK6 (PubMed:20873783).
CC       {ECO:0000250|UniProtKB:Q06507, ECO:0000269|PubMed:15109498,
CC       ECO:0000269|PubMed:20873783, ECO:0000269|PubMed:23123191}.
CC   -!- PTM: Hydroxylated by PHD3, leading to decreased protein stability.
CC       {ECO:0000305|PubMed:17684156}.
CC   -!- SIMILARITY: Belongs to the bZIP family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/44413/ATF4";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D90209; BAA14234.1; -; mRNA.
DR   EMBL; M86842; AAA52071.1; -; mRNA.
DR   EMBL; CR456384; CAG30270.1; -; mRNA.
DR   EMBL; AL022312; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60341.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW60342.1; -; Genomic_DNA.
DR   EMBL; BC008090; AAH08090.1; -; mRNA.
DR   EMBL; BC011994; AAH11994.1; -; mRNA.
DR   EMBL; BC016855; AAH16855.1; -; mRNA.
DR   EMBL; BC022088; AAH22088.1; -; mRNA.
DR   EMBL; BC024775; AAH24775.1; -; mRNA.
DR   EMBL; BC044895; AAH44895.1; -; mRNA.
DR   EMBL; BC073754; AAH73754.1; -; mRNA.
DR   EMBL; BC073990; AAH73990.1; -; mRNA.
DR   CCDS; CCDS13996.1; -.
DR   PIR; A45377; A45377.
DR   RefSeq; NP_001666.2; NM_001675.4.
DR   RefSeq; NP_877962.1; NM_182810.3.
DR   RefSeq; XP_016884296.1; XM_017028807.1.
DR   PDB; 1CI6; X-ray; 2.60 A; A=280-341.
DR   PDBsum; 1CI6; -.
DR   AlphaFoldDB; P18848; -.
DR   SMR; P18848; -.
DR   BioGRID; 106958; 96.
DR   ComplexPortal; CPX-6385; bZIP transcription factor complex, ATF3-ATF4.
DR   ComplexPortal; CPX-6408; bZIP transcription factor complex, ATF2-ATF4.
DR   ComplexPortal; CPX-6521; bZIP transcription factor complex, ATF4-ATF4.
DR   ComplexPortal; CPX-6522; bZIP transcription factor complex, ATF4-BATF.
DR   ComplexPortal; CPX-6523; bZIP transcription factor complex, ATF4-BATF2.
DR   ComplexPortal; CPX-6524; bZIP transcription factor complex, ATF4-BATF3.
DR   ComplexPortal; CPX-6525; bZIP transcription factor complex, ATF4-CEBPA.
DR   ComplexPortal; CPX-6526; bZIP transcription factor complex, ATF4-CEBPB.
DR   ComplexPortal; CPX-6527; bZIP transcription factor complex, ATF4-CEBPG.
DR   ComplexPortal; CPX-6528; bZIP transcription factor complex, ATF4-CEBPD.
DR   ComplexPortal; CPX-6529; bZIP transcription factor complex, ATF4-CEBPE.
DR   ComplexPortal; CPX-6541; bZIP transcription factor complex, ATF4-CREB3.
DR   ComplexPortal; CPX-6542; bZIP transcription factor complex, ATF4-CREBZF.
DR   ComplexPortal; CPX-6543; bZIP transcription factor complex, ATF4-DDIT3.
DR   ComplexPortal; CPX-6562; bZIP transcription factor complex, ATF4-JUN.
DR   ComplexPortal; CPX-6563; bZIP transcription factor complex, ATF4-JUNB.
DR   ComplexPortal; CPX-6564; bZIP transcription factor complex, ATF4-FOS.
DR   ComplexPortal; CPX-6565; bZIP transcription factor complex, ATF4-FOSL1.
DR   ComplexPortal; CPX-6566; bZIP transcription factor complex, ATF4-MAF.
DR   ComplexPortal; CPX-6567; bZIP transcription factor complex, ATF4-MAFB.
DR   ComplexPortal; CPX-6568; bZIP transcription factor complex, ATF4-NFE2.
DR   ComplexPortal; CPX-6569; bZIP transcription factor complex, ATF4-NFE2L1.
DR   ComplexPortal; CPX-6570; bZIP transcription factor complex, ATF4-NFE2L2.
DR   ComplexPortal; CPX-6572; bZIP transcription factor complex, ATF4-NFE2L3.
DR   ComplexPortal; CPX-8; bZIP transcription factor complex, ATF4-CREB1.
DR   ComplexPortal; CPX-9; bZIP transcription factor complex, ATF1-ATF4.
DR   CORUM; P18848; -.
DR   DIP; DIP-354N; -.
DR   ELM; P18848; -.
DR   FunCoup; P18848; 2624.
DR   IntAct; P18848; 80.
DR   MINT; P18848; -.
DR   STRING; 9606.ENSP00000336790; -.
DR   BindingDB; P18848; -.
DR   DrugBank; DB00852; Pseudoephedrine.
DR   GlyGen; P18848; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P18848; -.
DR   PhosphoSitePlus; P18848; -.
DR   BioMuta; ATF4; -.
DR   DMDM; 116241262; -.
DR   jPOST; P18848; -.
DR   MassIVE; P18848; -.
DR   PaxDb; 9606-ENSP00000336790; -.
DR   PeptideAtlas; P18848; -.
DR   ProteomicsDB; 53615; -.
DR   ABCD; P18848; 1 sequenced antibody.
DR   Antibodypedia; 12687; 1128 antibodies from 46 providers.
DR   DNASU; 468; -.
DR   Ensembl; ENST00000337304.2; ENSP00000336790.2; ENSG00000128272.19.
DR   Ensembl; ENST00000396680.3; ENSP00000379912.1; ENSG00000128272.19.
DR   Ensembl; ENST00000404241.7; ENSP00000384587.2; ENSG00000128272.19.
DR   Ensembl; ENST00000674568.2; ENSP00000501783.2; ENSG00000128272.19.
DR   Ensembl; ENST00000674835.2; ENSP00000502610.2; ENSG00000128272.19.
DR   Ensembl; ENST00000674920.3; ENSP00000501863.1; ENSG00000128272.19.
DR   Ensembl; ENST00000676346.2; ENSP00000502400.2; ENSG00000128272.19.
DR   Ensembl; ENST00000679776.1; ENSP00000505360.1; ENSG00000128272.19.
DR   GeneID; 468; -.
DR   KEGG; hsa:468; -.
DR   MANE-Select; ENST00000674920.3; ENSP00000501863.1; NM_182810.3; NP_877962.1.
DR   UCSC; uc003axz.4; human.
DR   AGR; HGNC:786; -.
DR   CTD; 468; -.
DR   DisGeNET; 468; -.
DR   GeneCards; ATF4; -.
DR   HGNC; HGNC:786; ATF4.
DR   HPA; ENSG00000128272; Low tissue specificity.
DR   MalaCards; ATF4; -.
DR   MIM; 604064; gene.
DR   OpenTargets; ENSG00000128272; -.
DR   VEuPathDB; HostDB:ENSG00000128272; -.
DR   eggNOG; KOG4571; Eukaryota.
DR   GeneTree; ENSGT00530000063801; -.
DR   HOGENOM; CLU_055748_1_0_1; -.
DR   InParanoid; P18848; -.
DR   OMA; ATIQEFH; -.
DR   OrthoDB; 5847285at2759; -.
DR   PAN-GO; P18848; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; P18848; -.
DR   PathwayCommons; P18848; -.
DR   Reactome; R-HSA-380994; ATF4 activates genes in response to endoplasmic reticulum stress.
DR   Reactome; R-HSA-381042; PERK regulates gene expression.
DR   Reactome; R-HSA-381183; ATF6 (ATF6-alpha) activates chaperone genes.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-9648895; Response of EIF2AK1 (HRI) to heme deficiency.
DR   Reactome; R-HSA-9818027; NFE2L2 regulating anti-oxidant/detoxification enzymes.
DR   Reactome; R-HSA-9818035; NFE2L2 regulating ER-stress associated genes.
DR   SignaLink; P18848; -.
DR   SIGNOR; P18848; -.
DR   BioGRID-ORCS; 468; 451 hits in 1147 CRISPR screens.
DR   ChiTaRS; ATF4; human.
DR   EvolutionaryTrace; P18848; -.
DR   GeneWiki; ATF4; -.
DR   GenomeRNAi; 468; -.
DR   Pharos; P18848; Tbio.
DR   PRO; PR:P18848; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P18848; protein.
DR   Bgee; ENSG00000128272; Expressed in muscle layer of sigmoid colon and 98 other cell types or tissues.
DR   ExpressionAtlas; P18848; baseline and differential.
DR   GO; GO:1990590; C:ATF1-ATF4 transcription factor complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990589; C:ATF4-CREB1 transcription factor complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005813; C:centrosome; IEA:UniProtKB-SubCell.
DR   GO; GO:1990617; C:CHOP-ATF4 complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0032590; C:dendrite membrane; IEA:Ensembl.
DR   GO; GO:1990037; C:Lewy body core; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043005; C:neuron projection; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0034399; C:nuclear periphery; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; IPI:ComplexPortal.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0140296; F:general transcription initiation factor binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0043522; F:leucine zipper domain binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; IDA:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0030282; P:bone mineralization; ISS:UniProtKB.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; ISS:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:1990253; P:cellular response to leucine starvation; IDA:MGI.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0034644; P:cellular response to UV; ISS:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0035162; P:embryonic hemopoiesis; ISS:UniProtKB.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; ISS:UniProtKB.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl.
DR   GO; GO:0006094; P:gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0140468; P:HRI-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0140467; P:integrated stress response signaling; IDA:UniProtKB.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0070982; P:L-asparagine metabolic process; IDA:UniProtKB.
DR   GO; GO:0070309; P:lens fiber cell morphogenesis; ISS:UniProtKB.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:1903377; P:negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0032057; P:negative regulation of translational initiation in response to stress; ISS:UniProtKB.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0070169; P:positive regulation of biomineral tissue development; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:ARUK-UCL.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:2000120; P:positive regulation of sodium-dependent phosphate transport; IEA:Ensembl.
DR   GO; GO:0045943; P:positive regulation of transcription by RNA polymerase I; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:1905461; P:positive regulation of vascular associated smooth muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:ComplexPortal.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   GO; GO:1990737; P:response to manganese-induced endoplasmic reticulum stress; IEA:Ensembl.
DR   GO; GO:0031667; P:response to nutrient levels; IDA:UniProtKB.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISS:UniProtKB.
DR   CDD; cd14692; bZIP_ATF4; 1.
DR   FunFam; 1.20.5.170:FF:000021; Cyclic AMP-dependent transcription factor ATF-4; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR046347; bZIP_sf.
DR   PANTHER; PTHR13044; ACTIVATING TRANSCRIPTION FACTOR ATF 4/5; 1.
DR   PANTHER; PTHR13044:SF2; CYCLIC AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-4; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
DR   neXtProt; NX_P18848; -.
DR   PharmGKB; PA25086; -.
DR   TreeFam; TF316136; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Biological rhythms; Cell membrane;
KW   Coiled coil; Cytoplasm; Cytoskeleton; DNA-binding; Hydroxylation;
KW   Isopeptide bond; Membrane; Nucleus; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..351
FT                   /note="Cyclic AMP-dependent transcription factor ATF-4"
FT                   /id="PRO_0000076584"
FT   DOMAIN          278..341
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          210..268
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          280..300
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          305..341
FT                   /note="Interaction with GABBR1"
FT                   /evidence="ECO:0000250"
FT   REGION          306..334
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   COILED          280..340
FT   MOTIF           215..224
FT                   /note="BetaTrCP degron motif"
FT                   /evidence="ECO:0000269|PubMed:11238952"
FT   COMPBIAS        230..246
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         213
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         215
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23123191"
FT   MOD_RES         219
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         224
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         235
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         236
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         245
FT                   /note="Phosphoserine; by RPS6KA3"
FT                   /evidence="ECO:0000269|PubMed:15109498"
FT   MOD_RES         248
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06507"
FT   MOD_RES         311
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:16219772"
FT   CROSSLNK        53
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        259
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        267
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        272
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         22
FT                   /note="Q -> P (in dbSNP:rs4894)"
FT                   /evidence="ECO:0000269|PubMed:1534408,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:1847461"
FT                   /id="VAR_028253"
FT   VARIANT         258
FT                   /note="P -> A (in dbSNP:rs1803323)"
FT                   /id="VAR_029259"
FT   VARIANT         322
FT                   /note="E -> D (in dbSNP:rs1803324)"
FT                   /id="VAR_014768"
FT   MUTAGEN         156
FT                   /note="P->A: Increased stability in low oxygen conditions;
FT                   when associated with A-162, A-164, A-167 and A-174."
FT                   /evidence="ECO:0000269|PubMed:17684156"
FT   MUTAGEN         162
FT                   /note="P->A: Increased stability in low oxygen conditions;
FT                   when associated with A-156, A-164, A-167 and A-174."
FT                   /evidence="ECO:0000269|PubMed:17684156"
FT   MUTAGEN         164
FT                   /note="P->A: Increased stability in low oxygen conditions;
FT                   when associated with A-156, A-162, A-167 and A-174."
FT                   /evidence="ECO:0000269|PubMed:17684156"
FT   MUTAGEN         167
FT                   /note="P->A: Increased stability in low oxygen conditions;
FT                   when associated with A-156, A-162, A-164 and A-174."
FT                   /evidence="ECO:0000269|PubMed:17684156"
FT   MUTAGEN         174
FT                   /note="P->A: Increased stability in low oxygen conditions;
FT                   when associated with A-156, A-162, A-164 and A-167."
FT                   /evidence="ECO:0000269|PubMed:17684156"
FT   MUTAGEN         213
FT                   /note="T->A: Does not affect phosphorylation by CK2."
FT                   /evidence="ECO:0000269|PubMed:23123191"
FT   MUTAGEN         215
FT                   /note="S->A: Abolished phosphorylation by CK2 leading to
FT                   increased stability."
FT                   /evidence="ECO:0000269|PubMed:23123191"
FT   MUTAGEN         219
FT                   /note="S->N: Abolished phosphorylation on the betaTrCP
FT                   degron motif, interaction with BTRC and subsequent
FT                   ubiquitination."
FT                   /evidence="ECO:0000269|PubMed:16219772"
FT   MUTAGEN         245
FT                   /note="S->A: Abolished phosphorylation by RPS6KA3/RSK2."
FT                   /evidence="ECO:0000269|PubMed:15109498"
FT   MUTAGEN         311
FT                   /note="K->R: Decreased acetylation without affecting
FT                   ubiquitination by SCF(BTRC)."
FT                   /evidence="ECO:0000269|PubMed:16219772"
FT   CONFLICT        284
FT                   /note="K -> R (in Ref. 7; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        290
FT                   /note="T -> R (in Ref. 7; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        329..331
FT                   /note="KEI -> REK (in Ref. 7; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        338
FT                   /note="I -> L (in Ref. 7; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   HELIX           288..340
FT                   /evidence="ECO:0007829|PDB:1CI6"
SQ   SEQUENCE   351 AA;  38590 MW;  3BBB7379DC3B0D07 CRC64;
     MTEMSFLSSE VLVGDLMSPF DQSGLGAEES LGLLDDYLEV AKHFKPHGFS SDKAKAGSSE
     WLAVDGLVSP SNNSKEDAFS GTDWMLEKMD LKEFDLDALL GIDDLETMPD DLLTTLDDTC
     DLFAPLVQET NKQPPQTVNP IGHLPESLTK PDQVAPFTFL QPLPLSPGVL SSTPDHSFSL
     ELGSEVDITE GDRKPDYTAY VAMIPQCIKE EDTPSDNDSG ICMSPESYLG SPQHSPSTRG
     SPNRSLPSPG VLCGSARPKP YDPPGEKMVA AKVKGEKLDK KLKKMEQNKT AATRYRQKKR
     AEQEALTGEC KELEKKNEAL KERADSLAKE IQYLKDLIEE VRKARGKKRV P
//
